● Recruiting

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

Condition: Hematologic Malignancies · Sponsor: Nanjing RegeneCore Biotech Co., Ltd.

PhasePhase 1

Planned participants71

Who can joinAll sexes, 18 Years to 74 Years

Healthy volunteersNo

About this study

This study is a first-in-human (FIH) study which is required to understand the safety, tolerability, pharmacokinetics and preliminary efficacy of RJK-RT2831 injection in patients with hematologic malignancies

This description comes directly from the study's public registry record.

Talk to the study team

Guo Qian · +86-025-58608860 · guoqian@regenecore.com

Wang J xiang

Always discuss trial participation with your own doctor first.

Locations (16)

The First Affiliated Hospital of USTC	Hefei, Anhui, China	Recruiting
The Second Hospital of Anhui Medical University	Hefei, Anhui, China	Recruiting
Guangdong Provincial People's Hospital	Guangzhou, Guangdong, China	Recruiting
Southern Medical University Nanfang Hospital	Guangzhou, Guangdong, China	Recruiting
Shenzhen People's Hospital	Shenzhen, Guangdong, China	Recruiting
The Affiliated Hospital of Guilin Medical University	Guilin, Guangxi, China	Recruiting
The First Affiliated Hospital of Guangxi Medical University	Nanning, Guangxi, China	Recruiting
Affiliated Hospital of Hebei University	Baoding, Hebei, China	Recruiting
Tangshan Central Hospital	Tangshan, Hebei, China	Recruiting
Henan Cancer Hospital	Zhengzhou, Henan, China	Recruiting
Zhongda Hospital Southeast University	Nanjing, Jiangsu, China	Recruiting
The First Affiliated Hospital of Soochow University	Suzhou, Jiangsu, China	Recruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06756451